Uloric is a xanthine oxidase inhibitor that is used in the treatment of gout. When the medicine works as intended, it prevents gout attacks from occurring. However, Uloric has been the subject of a recall request that has been made to the FDA in light of study results that have shown a linkage between the drug and increased cardiac deaths.
There has been an update to the boxed warning for the drug to reflect this added risk. Attorneys are now investigating the possibility of a Uloric lawsuit against the manufacturer of the drug on the grounds that the drug is defective.